DE59408715D1 - Cyclische Adhäsionsinhibitoren - Google Patents

Cyclische Adhäsionsinhibitoren

Info

Publication number
DE59408715D1
DE59408715D1 DE59408715T DE59408715T DE59408715D1 DE 59408715 D1 DE59408715 D1 DE 59408715D1 DE 59408715 T DE59408715 T DE 59408715T DE 59408715 T DE59408715 T DE 59408715T DE 59408715 D1 DE59408715 D1 DE 59408715D1
Authority
DE
Germany
Prior art keywords
lys
alanine
asp
atoms
prodn
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE59408715T
Other languages
English (en)
Inventor
Alfred Jonczyk
Guenter Hoelzemann
Brunhilde Felding-Habermann
Friedrich Rippmann
Beate Diefenbach
Horst Kessler
Roland Haubner
Jochen Wermuth
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Patent GmbH
Original Assignee
Merck Patent GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6484433&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE59408715(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Merck Patent GmbH filed Critical Merck Patent GmbH
Priority to DE59408715T priority Critical patent/DE59408715D1/de
Application granted granted Critical
Publication of DE59408715D1 publication Critical patent/DE59408715D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/75—Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
DE59408715T 1993-04-01 1994-03-21 Cyclische Adhäsionsinhibitoren Expired - Lifetime DE59408715D1 (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DE59408715T DE59408715D1 (de) 1993-04-01 1994-03-21 Cyclische Adhäsionsinhibitoren

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4310643A DE4310643A1 (de) 1993-04-01 1993-04-01 Cyclische Adhäsionsinhibitoren
DE59408715T DE59408715D1 (de) 1993-04-01 1994-03-21 Cyclische Adhäsionsinhibitoren

Publications (1)

Publication Number Publication Date
DE59408715D1 true DE59408715D1 (de) 1999-10-14

Family

ID=6484433

Family Applications (2)

Application Number Title Priority Date Filing Date
DE4310643A Withdrawn DE4310643A1 (de) 1993-04-01 1993-04-01 Cyclische Adhäsionsinhibitoren
DE59408715T Expired - Lifetime DE59408715D1 (de) 1993-04-01 1994-03-21 Cyclische Adhäsionsinhibitoren

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE4310643A Withdrawn DE4310643A1 (de) 1993-04-01 1993-04-01 Cyclische Adhäsionsinhibitoren

Country Status (20)

Country Link
US (2) US5849692A (de)
EP (1) EP0632053B1 (de)
JP (1) JP3694332B2 (de)
KR (1) KR100304201B1 (de)
CN (1) CN1056851C (de)
AT (1) ATE184288T1 (de)
AU (1) AU684489B2 (de)
CA (1) CA2120303C (de)
CZ (1) CZ286768B6 (de)
DE (2) DE4310643A1 (de)
DK (1) DK0632053T3 (de)
ES (1) ES2138632T3 (de)
GR (1) GR3032074T3 (de)
HU (1) HUT69726A (de)
NO (1) NO313756B1 (de)
PL (1) PL178791B1 (de)
RU (1) RU2130030C1 (de)
SK (1) SK281828B6 (de)
TW (1) TW343198B (de)
UA (1) UA34436C2 (de)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5753230A (en) * 1994-03-18 1998-05-19 The Scripps Research Institute Methods and compositions useful for inhibition of angiogenesis
DE4415310A1 (de) * 1994-04-30 1995-11-02 Merck Patent Gmbh Cyclopeptide
US7053041B1 (en) 1996-05-31 2006-05-30 The Scripps Research Institute Methods and compositions useful for inhibition of αvβ5mediated angiogenesis
DE19534016A1 (de) * 1995-09-14 1997-03-20 Merck Patent Gmbh Biotinderivate
DE19534177A1 (de) * 1995-09-15 1997-03-20 Merck Patent Gmbh Cyclische Adhäsionsinhibitoren
DE19538741A1 (de) * 1995-10-18 1997-04-24 Merck Patent Gmbh Cyclopeptidderivate
DE19613933A1 (de) * 1996-04-06 1997-10-09 Merck Patent Gmbh Cyclische Adhäsionsinhibitoren
RU2194528C2 (ru) 1996-05-31 2002-12-20 Дзе Скриппс Рисерч Инститьют Способы и композиции, используемые для ингибирования ангиогенеза
DE19736772A1 (de) * 1997-08-23 1999-02-25 Merck Patent Gmbh Cyclopeptidderivate
CA2356748A1 (en) 1998-12-23 2000-07-06 G.D. Searle & Co. Method of using an integrin antagonist and radiation therapy as combination therapy in the treatment of neoplasia
UA71608C2 (en) * 1999-03-11 2004-12-15 Merck Patent Gmbh A method for producing the cyclic pentapeptide
DE19933173A1 (de) 1999-07-15 2001-01-18 Merck Patent Gmbh Cyclische Peptidderivate als Inhibitoren des Integrins alpha¶v¶beta¶6¶
US6359015B1 (en) 2000-02-28 2002-03-19 The United States Of America As Represented By The Department Of Veterans Affairs Method for antagonizing inhibition effects of alcohol on cell adhesion
US6624187B1 (en) * 2000-06-12 2003-09-23 Health Research, Inc. Long wave length absorbing bacteriochlorin alkyl ether analogs
DE10040105A1 (de) 2000-08-17 2002-02-28 Merck Patent Gmbh Peptid- und Peptidmimetika-Derivate mit Integrin-Inhibitor-Eigenschaften
FR2814744B1 (fr) * 2000-10-04 2002-11-29 Commissariat Energie Atomique Cyclopeptides, leur procede de preparation et leur utilisation comme inhibiteur ou activateur de l'angiogenese
CN1507354A (zh) * 2001-03-02 2004-06-23 ͨ��ҽ�ƹ�˾ 通过给予整合蛋白αvβ3拮抗剂并与其它预防或治疗药剂配合来预防或者治疗炎性疾病或自身免疫疾病的方法
US7879267B2 (en) * 2001-08-02 2011-02-01 J&J Vision Care, Inc. Method for coating articles by mold transfer
WO2003075741A2 (en) * 2002-03-04 2003-09-18 Medimmune, Inc. METHODS OF PREVENTING OR TREATING DISORDERS BY ADMINISTERING AN INTEGRIN αvβ3 ANTAGONIST IN COMBINATION WITH AN HMG-CoA REDUCTASE INHIBITOR OR A BISPHOSPHONATE
CA2478239A1 (en) * 2002-03-04 2003-09-18 Medimmune, Inc. The prevention or treatment of cancer using integrin alphavbeta3 antagonists in combination with other agents
JP2005535572A (ja) * 2002-04-12 2005-11-24 メディミューン，インコーポレーテッド 組換え抗インターロイキン−９抗体
GB0217017D0 (en) * 2002-07-23 2002-08-28 Bioacta Ltd Peptide 2
ITRM20020402A1 (it) * 2002-07-29 2004-01-29 Sigma Tau Ind Farmaceuti Derivati fluoro-alchil-ciclopeptidi ad attivita' anti-integrine.
US6977272B2 (en) * 2002-10-16 2005-12-20 President And Fellows Of Harvard College Method for antagonizing inhibition effects of alcohol on cell adhesion
CA2514653A1 (en) * 2003-01-30 2004-08-12 Medimmune, Inc. Uses of integrin alphavbeta3 antagonists
US7354584B2 (en) 2003-04-11 2008-04-08 Medimmune, Inc. Recombinant IL-9 antibodies
US7351739B2 (en) * 2004-04-30 2008-04-01 Wellgen, Inc. Bioactive compounds and methods of uses thereof
ITRM20040239A1 (it) * 2004-05-13 2004-08-13 Sigma Tau Ind Farmaceuti Derivati ciclopeptidici ad attivita' antintegrine.
AU2005299355A1 (en) 2004-10-27 2006-05-04 Medimmune, Llc Modulation of antibody specificity by tailoring the affinity to cognate antigens
EP2043603A4 (de) 2006-07-11 2010-10-27 Arubor Corp Prävention und therapie von rhinosinusitis mit proinflammatorischen zytokinhemmern
LT2068889T (lt) 2006-08-10 2020-02-10 Roy C. Levitt Anakinra, naudojama bronchiolito obliteranso sindromo gydymui
US7842662B2 (en) 2006-11-10 2010-11-30 Cara Therapeutics, Inc. Synthetic peptide amide dimers
ES2394377T3 (es) 2006-11-10 2013-01-31 Cara Therapeutics, Inc. Amidas de péptidos sintéticos
US8906859B2 (en) 2006-11-10 2014-12-09 Cera Therapeutics, Inc. Uses of kappa opioid synthetic peptide amides
US7713937B2 (en) 2006-11-10 2010-05-11 Cara Therapeutics, Inc. Synthetic peptide amides and dimeric forms thereof
US8236766B2 (en) 2006-11-10 2012-08-07 Cara Therapeutics, Inc. Uses of synthetic peptide amides
WO2009124754A1 (en) * 2008-04-08 2009-10-15 Merck Patent Gmbh Compositions containing cyclic peptides and methods of use
BRPI0920108A2 (pt) 2008-10-23 2016-12-13 Steba Biotech N V peptídomimético cíclico contendo argina, glicina, ácido aspártico (rgd), conjugado de peptidomimético cíclico contendo rgd, composição farmacêutica, conjugado e uso do mesmo.
CN101906141B (zh) * 2009-06-02 2013-04-17 首都医科大学 一类肽链与双脂肪醇链的偶联物及其制备方法和应用
CN101906144B (zh) * 2009-06-03 2013-06-19 首都医科大学 一根Arg-Gly-Asp-Val链通过Asp与两根脂肪醇链的偶联物、它们的合成及在医学中的应用
RU2655763C2 (ru) * 2016-10-24 2018-05-29 Общество С Ограниченной Ответственностью "Айвикс" Фармацевтическая композиция и способ лечения женских сексуальных дисфункций
RU2626002C1 (ru) 2016-10-24 2017-07-21 Общество С Ограниченной Ответственностью "Айвикс" Новая группа пептидов для лечения женской сексуальной дисфункции
US10494403B2 (en) 2018-03-06 2019-12-03 Ciphore Biomed Technology Limited Company Cyclopeptide, pharmaceutical or cosmetic composition comprising the same and method for preparing the same

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4472305A (en) * 1983-05-17 1984-09-18 Sterling Drug Inc. Hexapeptide amides
JP2945680B2 (ja) * 1988-09-09 1999-09-06 旭硝子株式会社 ペプチド誘導体およびその用途
US5192746A (en) * 1990-07-09 1993-03-09 Tanabe Seiyaku Co., Ltd. Cyclic cell adhesion modulation compounds
JPH04264097A (ja) * 1991-02-16 1992-09-18 Asahi Glass Co Ltd ペプチド誘導体およびその用途
HUT63609A (en) * 1992-03-10 1993-09-28 Sandoz Ag Process for producing new derivatives and isosters of beta-amino acids and pharmaceutical compositions comprising such compounds
UA43823C2 (uk) * 1992-07-06 2002-01-15 Мерк Патент Геселлшафт Міт Бесшренктер Хафтунг ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ ДЛЯ ІНГІБУВАННЯ ІНТЕГРИН <font face="Symbol">a</font><sub>V</sub><font face="Symbol">b</font><sub>3</sub>-ОПОСЕРЕДКОВАНОЇ КЛІТИННОЇ АДГЕЗІЇ КЛІТИН ССАВЦІВ, СПОСІБ ЛІКУВАННЯ ТА ПРОФІЛАКТИКИ ЗАХВОРЮВАННЯ, АСОЦІЙОВАНОГО З ПОРУШЕННЯМ АДГЕЗІЇ КЛІТИН, СПОСІБ БЛОКУВАННЯ ЗВ'ЯЗУВАННЯ ФІБРИНОГЕНОМ ІНТЕГРИНУ, КОМПОЗИЦІЯ ДЛЯ ЗАГОЄННЯ РАН
US5753230A (en) * 1994-03-18 1998-05-19 The Scripps Research Institute Methods and compositions useful for inhibition of angiogenesis

Also Published As

Publication number Publication date
TW343198B (en) 1998-10-21
NO941152L (no) 1994-10-03
CN1056851C (zh) 2000-09-27
KR100304201B1 (ko) 2001-11-30
CA2120303A1 (en) 1994-10-02
RU2130030C1 (ru) 1999-05-10
CZ70494A3 (en) 1995-01-18
CZ286768B6 (en) 2000-07-12
JP3694332B2 (ja) 2005-09-14
PL178791B1 (pl) 2000-06-30
HUT69726A (en) 1995-09-28
NO313756B1 (no) 2002-11-25
EP0632053A2 (de) 1995-01-04
JPH06329698A (ja) 1994-11-29
GR3032074T3 (en) 2000-03-31
AU684489B2 (en) 1997-12-18
US6169072B1 (en) 2001-01-02
DE4310643A1 (de) 1994-10-06
SK38394A3 (en) 1995-02-08
EP0632053A3 (de) 1995-02-15
CA2120303C (en) 2007-05-01
DK0632053T3 (da) 2000-03-13
US5849692A (en) 1998-12-15
CN1099760A (zh) 1995-03-08
EP0632053B1 (de) 1999-09-08
NO941152D0 (no) 1994-03-29
AU5918594A (en) 1994-10-06
ATE184288T1 (de) 1999-09-15
UA34436C2 (uk) 2001-03-15
HU9400937D0 (en) 1994-06-28
SK281828B6 (sk) 2001-08-06
ES2138632T3 (es) 2000-01-16

Similar Documents

Publication Publication Date Title
DK0632053T3 (da) Cykliske adhæsionsinhibitorer
CA1315479C (en) Platelet-aggregation inhibitor peptide derivatives
DE69434538D1 (de) Vaskularer endothelialer wachstumsfaktor 2
ES2144179T3 (es) Inhibidores de adhesion ciclicos.
US5061693A (en) Fibrinogen receptor antagonists
CA2027315A1 (en) Fibrinogen receptor antagonists
RU94011276A (ru) Циклопептиды, способ их получения, содержащие их фармацевтические композиции и способ их получения
EP0410541A1 (de) Fibrinogenrezeptorantagonisten
EP0411833A1 (de) Fibrinogenrezeptorantagonisten
FR2591485B1 (fr) Compositions stabilisees contenant l&#39;activateur du plasminogene du tissu humain.
KR930007972A (ko) 환상 혈관활성 펩티드
DK0585397T3 (da) Bombesinanaloger
KR880001696A (ko) 레닌 억제용 디- 및 트리 펩타이드 및 이의 제조방법
NO941151L (no) Lineære adhesjonsinhibitorer
DK0393934T3 (da) Nye peptider samt antidemensmidler indeholdende disse peptider
NO983177L (no) Anvendelse av 1-enantiomeren av centkroman til fremstilling av et farmasaytisk preparat for behandling eller profylakse av brystkreft
DK1309613T3 (da) Farmaceutisk præparat omfattende et analgetisk peptid
EP0182627A3 (de) Basische V1-Basopressin-Antagonisten
KR910016768A (ko) 아미노산 유도체
NO975565L (no) Benstimulerende faktor
Fressinaud et al. Synthetic RGDS-containing peptides of von Willebrand factor inhibit platelet adhesion to collagen
DK0552106T3 (da) Peptider med antagonistaktivitet over for bradykinin
YU48997A (sh) Novi biološki aktivni proteini, njihove farmaceutske smeše i postupak za njihovo dobijanje
KR960703612A (ko) 면역계 및 중추 신경계 치료용 신규의 트리펩티드(novel tripeptides useful in immune and cns therapy)
EP0791350A3 (de) Mittel zur dauerhaften Verformung von menschlichen Haaren

Legal Events

Date Code Title Description
8364 No opposition during term of opposition